Bill
Bill > HB830
VA HB830
VA HB830Pharmacy benefits managers; requirements, application of law, report, delayed effective date.
summary
Introduced
01/13/2026
01/13/2026
In Committee
03/06/2026
03/06/2026
Crossed Over
03/11/2026
03/11/2026
Passed
04/13/2026
04/13/2026
Dead
Signed/Enacted/Adopted
04/13/2026
04/13/2026
Introduced Session
2026 Regular Regular Session
Bill Summary
Pharmacy benefits managers; requirements; scope; report. Requires all health insurance carriers to use the pass-through pricing model and may limit a pharmacy benefits manager from deriving income from pharmacy benefits management services provided to a carrier except for income derived from a pharmacy benefits management fee. The bill prohibits a pharmacy benefits manager from (i) reversing and or resubmitting the claim of a pharmacist or pharmacy without meeting certain requirements, (ii) reducing any payment to a pharmacist or pharmacy to an effective rate of reimbursement, or (iii) retroactively denying or reducing a claim or aggregate of claims except under certain circumstances. The bill requires the State Corporation Commission (the Commission) to examine the practice of carriers or pharmacy benefits managers requiring or inducing covered individuals to utilize pharmacy services at an affiliated pharmacy. The Commission is required to report its findings and recommendations to the General Assembly by December 1, 2027. Certain provisions of the bill have a delayed effective date of July 1, 2027. This bill is identical to SB 669.
AI Summary
This bill mandates that pharmacy benefits managers (PBMs), which are companies that manage prescription drug benefits on behalf of health insurers or employers, must adopt a "pass-through pricing model," meaning they cannot profit from the difference between what they pay pharmacies and what they charge the insurer, except for a set fee for their services. It also prohibits PBMs from reversing or resubmitting pharmacy claims without proper justification and notification, from reducing payments to pharmacies to an unfairly low rate, or from retroactively denying or reducing payments for claims except in specific cases like fraud. The bill extends these PBM requirements to the state employee health plan and mandates that the State Corporation Commission (the Commission) will annually report on the impact of prescription drug costs on healthcare premiums and investigate whether insurers or PBMs unfairly steer patients to affiliated pharmacies, with findings due to the General Assembly by December 1, 2026, and the main provisions taking effect on July 1, 2027.
Committee Categories
Budget and Finance, Business and Industry
Sponsors (31)
Katrina Callsen (D)*,
Kimberly Adams (D),
Jessica Anderson (D),
Bonita Anthony (D),
Elizabeth Bennett-Parker (D),
Gretchen Bulova (D),
Kacey Carnegie (D),
Stacey Carroll (D),
Nadarius Clark (D),
Nicole Cole (D),
Rae Cousins (D),
Lindsey Dougherty (D),
Mark Downey (D),
Lily Franklin (D),
Margaret Franklin (D),
Elizabeth Guzmán (D),
Phil Hernandez (D),
Karen Keys-Gamarra (D),
Amy Laufer (D),
Fernando Martinez (D),
Adele McClure (D),
Leslie Chambers Mehta (D),
May Nivar (D),
Marcia Price (D),
Sam Rasoul (D),
Charlie Schmidt (D),
Shelly Simonds (D),
Virgil Thornton (D),
Kathy Tran (D),
Howard Wachsmann (R),
Rodney Willett (D),
Last Action
Approved by Governor-Chapter 678 (effective 7/1/2026) (on 04/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...